Biotechnology Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise – Lipella Pharmaceuticals (NASDAQ:LIPO) Read more
Biotechnology Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024 – Lipella Pharmaceuticals (NASDAQ:LIPO) Read more
Stockmarkets Lipella Pharmaceuticals executive Kaufman buys $45k in stock By biedexmarkets.com Read more
Biotechnology Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline – Lipella Pharmaceuticals (NASDAQ:LIPO) Read more
Biotechnology Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference – Lipella Pharmaceuticals (NASDAQ:LIPO) Read more
